DK0799210T3 - Piperazin-2,5-dionderivater som modulatorer af multiresistens - Google Patents

Piperazin-2,5-dionderivater som modulatorer af multiresistens

Info

Publication number
DK0799210T3
DK0799210T3 DK95941799T DK95941799T DK0799210T3 DK 0799210 T3 DK0799210 T3 DK 0799210T3 DK 95941799 T DK95941799 T DK 95941799T DK 95941799 T DK95941799 T DK 95941799T DK 0799210 T3 DK0799210 T3 DK 0799210T3
Authority
DK
Denmark
Prior art keywords
pct
modulators
formula
piperazine
resistance
Prior art date
Application number
DK95941799T
Other languages
Danish (da)
English (en)
Inventor
Philip Anthony Ashworth
Sukhjit Hunjan
Ian Andrew Pretswell
Hamish Ryder
Stephen James Brocchini
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Application granted granted Critical
Publication of DK0799210T3 publication Critical patent/DK0799210T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electron Tubes For Measurement (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK95941799T 1994-12-23 1995-12-22 Piperazin-2,5-dionderivater som modulatorer af multiresistens DK0799210T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426090.8A GB9426090D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds
PCT/GB1995/003029 WO1996020180A1 (fr) 1994-12-23 1995-12-22 Derives de la piperazine-2,5-dione employes comme modulateurs de la resistance multiple aux anticancereux

Publications (1)

Publication Number Publication Date
DK0799210T3 true DK0799210T3 (da) 2001-10-01

Family

ID=10766502

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95941799T DK0799210T3 (da) 1994-12-23 1995-12-22 Piperazin-2,5-dionderivater som modulatorer af multiresistens

Country Status (28)

Country Link
US (1) US5935955A (fr)
EP (1) EP0799210B1 (fr)
JP (1) JPH10511385A (fr)
KR (1) KR100412167B1 (fr)
CN (1) CN1108294C (fr)
AT (1) ATE204569T1 (fr)
AU (1) AU700891B2 (fr)
BG (1) BG63305B1 (fr)
BR (1) BR9510429A (fr)
CA (1) CA2207548A1 (fr)
CZ (1) CZ288935B6 (fr)
DE (1) DE69522342T2 (fr)
DK (1) DK0799210T3 (fr)
ES (1) ES2160726T3 (fr)
FI (1) FI972661A (fr)
GB (2) GB9426090D0 (fr)
HK (1) HK1001974A1 (fr)
HU (1) HUT77740A (fr)
IL (1) IL116526A (fr)
MY (1) MY131762A (fr)
NO (1) NO308532B1 (fr)
NZ (1) NZ297849A (fr)
PL (1) PL186851B1 (fr)
PT (1) PT799210E (fr)
SK (1) SK283385B6 (fr)
UA (1) UA61879C2 (fr)
WO (1) WO1996020180A1 (fr)
ZA (1) ZA9510908B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
MA26696A1 (fr) 1998-10-08 2004-12-20 Smithkline Beecham Plc Derives de tetrahydrobenzazepine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
US6828412B1 (en) * 1999-09-03 2004-12-07 School Of Pharmacy, University Of London Degradable polymers
AU7346400A (en) * 1999-09-03 2001-04-10 School Of Pharmacy, University Of London, The Degradable polymers
CA2385528C (fr) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions et methodes de traitement du cancer utilisant des immunoconjugues et des agents chimiotherapeutiques
ATE377048T1 (de) 2000-09-06 2007-11-15 Ap Pharma Inc Abbaubare polyacetal-polymere
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US20030109448A1 (en) * 2001-11-07 2003-06-12 Crowley Kathleen S. Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
US8710062B2 (en) * 2011-03-11 2014-04-29 Taipei Medical University Piperazinedione compounds
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
AU2019416623B2 (en) * 2018-12-27 2022-12-08 Holosmedic Novel compound and pharmaceutical composition comprising same for enhancing anticancer activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663179A (en) * 1992-07-10 1997-09-02 Laboratoires Glaxo Sa Certain isoquinoline derivatives having anti-tumor properties
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds
US5460977A (en) * 1992-08-14 1995-10-24 Torii & Co. Peptide having allergenicity
GB9402807D0 (en) * 1994-02-14 1994-04-06 Xenova Ltd Pharmaceutical compounds
GB9410387D0 (en) * 1994-05-24 1994-07-13 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
BR9510429A (pt) 1998-07-07
GB2311780A (en) 1997-10-08
EP0799210A1 (fr) 1997-10-08
DE69522342T2 (de) 2002-01-03
BG63305B1 (bg) 2001-09-28
AU4310296A (en) 1996-07-19
CN1176637A (zh) 1998-03-18
PL186851B1 (pl) 2004-03-31
ES2160726T3 (es) 2001-11-16
HK1001974A1 (en) 1998-07-24
WO1996020180A1 (fr) 1996-07-04
FI972661A (fi) 1997-08-22
ATE204569T1 (de) 2001-09-15
GB2311780B (en) 1999-03-03
SK283385B6 (sk) 2003-06-03
NO308532B1 (no) 2000-09-25
PL320915A1 (en) 1997-11-10
MY131762A (en) 2007-08-30
IL116526A (en) 1999-11-30
CN1108294C (zh) 2003-05-14
EP0799210B1 (fr) 2001-08-22
DE69522342D1 (de) 2001-09-27
FI972661A0 (fi) 1997-06-19
HUT77740A (hu) 1998-07-28
US5935955A (en) 1999-08-10
AU700891B2 (en) 1999-01-14
JPH10511385A (ja) 1998-11-04
NO972938L (no) 1997-06-23
CZ190297A3 (cs) 1998-01-14
CZ288935B6 (cs) 2001-09-12
NO972938D0 (no) 1997-06-23
NZ297849A (en) 1999-04-29
CA2207548A1 (fr) 1996-07-04
PT799210E (pt) 2002-01-30
GB9712179D0 (en) 1997-08-13
BG101601A (en) 1998-02-27
KR100412167B1 (ko) 2004-05-27
SK83597A3 (en) 1998-04-08
UA61879C2 (en) 2003-12-15
GB9426090D0 (en) 1995-02-22
ZA9510908B (en) 1996-06-24
IL116526A0 (en) 1996-03-31

Similar Documents

Publication Publication Date Title
TR199700419A2 (xx) Yeni piridazinon t�revleri.
DK0865281T3 (da) Naphthylsubstituerede benzimidazolderivater som antikoagulerende midler
EA199800141A1 (ru) Гетероциклические соединения
ATE342256T1 (de) Chinazolinderivate als medikamente
DK0799210T3 (da) Piperazin-2,5-dionderivater som modulatorer af multiresistens
DK0677046T3 (da) Piperazinderivater som 5-HT-antagonister.
MX9300552A (es) Derivados de etanolamina
DK0632805T3 (da) Melaminderivater til anvendelse i behandlingen af cancer
AUPN952696A0 (en) New heterocyclic compounds
DK0777653T3 (da) Dihydropyridinderivater som bradykininantagonister
ATE172454T1 (de) Pyridazinon derivate mit pharmazeutischer wirkung
DK0625982T3 (da) 4-Oxo- og 4H-imidazo(5,1-c)(1,4)benzoxaziner anvendelige som benzodiazepinreceptor-bindemidler
IT1292155B1 (it) Derivati naftotiazolonici attivi sul recettore dopaminergico d 3
ATE278676T1 (de) Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren
ATE202108T1 (de) Cephemverbindungen
TR199701289T2 (xx) Karbapenemlerin esterleri
ES2088320T3 (es) Derivados de carboestirilo.